Dr. Geetha Manjunath is the founder, CEO, and CTO of NIRAMAI Health Analytix and has led the company to develop a breakthrough AI solution for detecting early-stage breast cancer in a non-invasive, radiation-free manner. Geetha is a gold medalist and PhD holder from the Indian Institute of Science with management education from Kellogg Chicago. She comes with over 30 years of experience in IT innovation. Before starting NIRAMAI, Geetha was a lab director heading AI research at Xerox and a principal scientist at Hewlett Packard Labs. Geetha has received much international and national recognition for her innovations and entrepreneurial work, including the CSI Gold Medal and the BIRAC WinER Award 2018, and is on the Forbes List of Top 20 Self-Made Women 2020. She was the winner of the Women Health Innovation Showcase Asia in Singapore, the Accenture Vahini Innovator of the Year Award from the Economic Times, and the Women Entrepreneur of the Year 2020 by BioSpectrum India. Geetha is an inventor of 50+ US patents, a senior member of the IEEE, and a Fellow of the Indian National Academy of Engineering (INAE).